Liminatus Pharma, Inc. (LIMN)
0.1875
-0.02
(-8.98%)
USD |
NASDAQ |
Apr 10, 16:00
0.1875
0.00 (0.00%)
After-Hours: 20:00
Liminatus Pharma Market Cap : 8.415M for April 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CDT Equity, Inc. | 19.27M |
| LENZ Therapeutics, Inc. | 284.38M |
| Oruka Therapeutics, Inc. | 2.952B |
| Maze Therapeutics, Inc. | 1.327B |
| MapLight Therapeutics, Inc. | 1.134B |
Market Cap Related Metrics
| PEG Ratio | -0.0016 |
| Price | 0.1875 |
| Earnings Yield | -194.3% |
| PEGY Ratio | -0.0016 |